1st Quarter Results

Summary by AI BETAClose X

Oxford Technology 2 VCT Plc reported its first quarter results ending 31 May 2026, with unaudited net asset values per share showing significant increases for OT1 (51.0p, up 24.1%), OT3 (24.0p, up 27.1%), and OT2 (19.4p, up 10.1%), primarily driven by the rise in Scancell Holdings Plc's share price. Conversely, the OT4 Share Class saw a decrease to 19.6p, down 3.9%, due to a decline in Arecor Therapeutics Plc's share price from 70p to 62p. The company sold approximately 8% of its Scancell holdings for liquidity, realizing multiples of 1.7 to 4.4 times original cost, while retaining nearly 10 million Scancell shares. Unquoted investments remained at their previous valuations.

Disclaimer*

UK 100

Latest directors dealings